About
Management team
Experienced team developing novel therapies for inherited retinal disorders
AAVantgarde is global biopharmaceutical company with operations in Italy and London. The team has a long track record of success in developing treatments for genetic therapies and inherited retinal disorders. The founder, Professor Alberto Auricchio, is a highly recognized scientist and a pioneer in large gene delivery.
Natalia Misciattelli PhD
Chief Executive Officer
Prof. Alberto Auricchio
Founder and Chief Science Officer
Dr. Jayashree Sahni
FRCOphth, EMBA, MD
Rasmus Holm-Jorgensen
Chief Financial Officer
Nina Kotsopoulou PhD
Chief Technical Officer
Mike Murtagh
Senior Vice President Regulatory
Magda Blanco PhD, MBA
Head of Corporate Development